Related Experiment Video
Updated: Aug 19, 2025

Complete and Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Hemorrhagic Shock
Published on: May 19, 2022
Severe Acute Blood Loss Anemia in Jehovah's Witnesses Undergoing Cardiac Surgery: Single Academic Center Experience
Mohammad A Helwani1, Charl J De Wet1, Bethany Pennington1
1Department of Anesthesiology, Washington University, St. Louis, MO.
Insights
Severe acute blood loss anemia (ABLA) in Jehovah
Area of Science:
- Cardiology
- Anesthesiology
- Transfusion Medicine
Background:
- Jehovah's Witness (JW) patients present unique challenges in cardiac surgery due to their refusal of blood transfusions.
- Severe acute blood loss anemia (ABLA) is a significant concern in the postoperative period for these patients.
- Understanding the impact of ABLA on outcomes is crucial for optimizing care.
Purpose of the Study:
- To investigate the association between severe acute blood loss anemia (ABLA) and postoperative outcomes in Jehovah's Witness (JW) patients undergoing cardiac surgery.
- To identify risk factors and consequences of ABLA in this specific patient population.
Main Methods:
- Retrospective cohort study of adult JW patients undergoing cardiac surgery with cardiopulmonary bypass (CPB).
- Patients were categorized into two groups: those who developed severe ABLA (postoperative hematocrit <21) and those who did not.
- Postoperative mortality and hospital length of stay were analyzed.
Main Results:
- Out of 48 JW patients, 18.8% developed severe ABLA.
- Severe ABLA was linked to increased 30-day, 90-day, and 1-year postoperative mortality.
- A trend towards increased hospital length of stay was observed in patients with severe ABLA.
Conclusions:
- Severe acute blood loss anemia following cardiac surgery is associated with significantly higher mortality in Jehovah's Witness patients.
- A trend towards prolonged hospitalization was noted.
- Further research is needed to confirm these findings and explore management strategies.
Objective:
To determine the effect of severe acute blood loss anemia (ABLA) on postoperative outcomes in Jehovah's Witness (JW) patients undergoing cardiac surgery.
Design:
This was a retrospective cohort study of adult JW patients undergoing cardiac surgery requiring cardiopulmonary bypass (CPB) between January 1998 and December 2018 at Barnes-Jewish Hospital in St. Louis, Missouri.
Setting:
At a single tertiary academic center.
Participants:
Patients who were JWs undergoing cardiac surgery requiring CPB.
Interventions:
Patients were divided into the following 2 groups: JW patients who developed severe ABLA (defined as postoperative hematocrit level <21), and patients who did not develop severe ABLA.
Measurements And Main Results:
A total of 48 JW patients who underwent cardiac surgery between 2008 and 2018 were identified. Of these patients, 9 (18.8%) developed postoperative severe ABLA, and 39 (81.3%) did not. Severe ABLA was associated with increased postoperative mortality at 30-days, 90-days, and 1-year postoperatively, and a trend toward increased hospital length of stay.
Conclusions:
Severe ABLA after cardiac surgery was associated with higher mortality and a trend toward increased hospital length of stay among JW patients. More data are required to confirm the findings.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Hemodialysis II: Procedure and Complications
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

